Agonist-induced Phosphorylation of the Angiotensin II (AT1A) Receptor Requires Generation of a Conformation That Is Distinct from the Inositol Phosphate-signaling State*
暂无分享,去创建一个
S. Karnik | H. Qian | W. Thomas | S Karnik | W G Thomas | H Qian | C S Chang | Chang-Sheng Chang
[1] P. Leff,et al. A Three‐State Receptor Model: Predictions of Multiple Agonist Pharmacology for the Same Receptor Type a , 1998, Annals of the New York Academy of Sciences.
[2] B. Maigret,et al. Mutation of Asn111 in the Third Transmembrane Domain of the AT1A Angiotensin II Receptor Induces Its Constitutive Activation* , 1997, The Journal of Biological Chemistry.
[3] R. Lefkowitz,et al. Constitutively active mutants of the alpha 2-adrenergic receptor. , 1993, The Journal of biological chemistry.
[4] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[5] R. Graham,et al. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. , 1996, Molecular pharmacology.
[6] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[7] M. Caron,et al. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features. , 1999, Molecular pharmacology.
[8] E. sanders-Bush,et al. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. , 1995, Molecular pharmacology.
[9] P. Corvol,et al. Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements , 1994, FEBS letters.
[10] M. Zuscik,et al. Identification of a Conserved Switch Residue Responsible for Selective Constitutive Activation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.
[11] H. Hasegawa,et al. Prostaglandin E receptor EP3γ isoform, with mostly full constitutive Gi activity and agonist‐dependent Gs activity , 1996, FEBS letters.
[12] T. Thekkumkara,et al. Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: MOLECULAR MECHANISMS OF ANGIOTENSIN II (AT1a) RECEPTOR ENDOCYTOSIS , 1996, Clinical and experimental pharmacology & physiology.
[13] R. Leurs,et al. Agonist-independent regulation of constitutively active G-protein-coupled receptors. , 1998, Trends in biochemical sciences.
[14] P. Leff. Inverse agonism: theory and practice. , 1995, Trends in pharmacological sciences.
[15] S. Swillens. How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. , 1992, Trends in pharmacological sciences.
[16] P. Leff,et al. A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.
[17] Robert J. Lefkowitz,et al. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.
[18] P. Leff,et al. The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.
[19] P. Corvol,et al. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] Terri L. Gilbert,et al. Multiple activation steps of the N-formyl peptide receptor. , 1999, Biochemistry.
[21] S. Miura,et al. Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor* , 1999, The Journal of Biological Chemistry.
[22] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[23] X. P. Liu,et al. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. , 1996, Biochemistry.
[24] K. Baker,et al. Stable expression of a truncated AT1A receptor in CHO-K1 cells. The carboxyl-terminal region directs agonist-induced internalization but not receptor signaling or desensitization. , 1995, The Journal of biological chemistry.
[25] D. Oprian,et al. Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin. , 1995, Biochemistry.
[26] L. Hunyady,et al. A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor (*) , 1995, The Journal of Biological Chemistry.
[27] A. Seibold,et al. β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.
[28] L. Hunyady,et al. Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. , 1998, Molecular pharmacology.
[29] S. Miura,et al. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). , 1998, Biochemistry.
[30] T. Thekkumkara,et al. Angiotensin II Receptor Endocytosis Involves Two Distinct Regions of the Cytoplasmic Tail , 1995, The Journal of Biological Chemistry.
[31] K. Jarnagin,et al. Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation. , 1996, Biochemistry.
[32] R. Lefkowitz,et al. A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. , 1994, Proceedings of the National Academy of Sciences of the United States of America.